NF-xB-dependent Fas ligand expression

European Journal of Immunology

Volumn 29, Issue 9, 1999, Pages 2948-2956

  Hsu, Shu Ching ^a,b   Gavrilin, Mikhail A ^b   Lee, Hsiu Hsiang ^a   Wu, Chia Cheng ^c   Han, Shouhwa ^b   Lai, Ming Zong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Activation induced cell death; Fas; Fas ligand; Nf xb

Indexed keywords

CYCLIC AMP; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STRESS; T LYMPHOCYTE ACTIVATION;

EID: 0033384179     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199909)29:09<2948::aid-immu2948>3.0.co;2-0     Document Type: Article

References (46)

1. Nagata, S., Apoptosis by death factor. Cell 1997. 88: 355-365.
2. Dhein, J., Walczak, H., Baumler, C., Debatin, K.-M. and Krammer, P. H., Autocrine T-cell suicide mediated by APOI-1 (Fas/CD95). Mature 1995. 373: 438-441.
3. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Cellautonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373:441-444. ,
4. Ju, S.-T., Panka, D. J., Cui, H., Ettiriger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z. and MarshakRothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995.373:444-448.
5. Vignaux, F., Vivier, E., Malissen, B., Depraetere, V., Nagata, S. and Golstein, P., TCR/CD3 coupling to Fasbased cytotoxicity. J. Exp. /Wed. 1995.181: 781-786.
6. Muller, M., Strand, S., Hug, H., Heineman, E., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H. and Galle, P. R., Drug-induced apoptosis'in hepatoma cells is mediated by CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. din. Invest. 1997.99:403-413.
7. Morita, A., Werfel, T., Stege, H., Ahrens, C., Karmann, K., Grewe, M., Grether-Beck, S., Ruzicka, T., Kapp, A., Klotz, L.-O., Sies, H. and Krutmann, J., Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J. Exp. Med. 1997. 185:1763-1768.
8. B Hug; H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H. and Galle, P. R., Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol. Chem. 1997. 272: 28191-28193.
9. Fan's, M., Kokot, N., Latinis, K., Kasibhatla, S., Green, D. R., Koretzky, G. A. and Nel, A., The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulation Fas ligand expression. J. Immunol. 1998.160:134-144.
10. Kasibhatla, S., Brunner, T., Genestier, L, Echeverri, F., Mahboubi, A. and Green, D. R., DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-xB and AP-1. Mol. Cell. 1998.1: 543-551.
11. Mo, Y.-Y. and Beck, W. T., DNA damage signals induction of Fas ligand in tumor cells. Mol. Pharmacol. 1999. 55:216-222.
12. Paris, M., Latinis, K., Kempiak, S. J., Koretzky, G. A. and Nel, A., Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol. Cell. Biol. 1998.18:5414-5424.
13. Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F. X., Green, D. R. and Karin, M., Withdrawal of survival factpr.s results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 1999.19: 751 -763.
14. Ivanov, V. N., Lee, R. K., Podack, E. R. and Malek, T. R., Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-xB. Oncogens 1997. 14: 2455-2464.
15. Latinis, K. M., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 1997.272:31427-31434.
16. Holtz-Heppelmann, C. J., Algeciras, A., Badley, A. D. and Paya, C. V., Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998. 273:4416-4423.
17. Norian, L. A., Latinis, K. M. and Koretzky, G. A., A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes. J. Immunol. 1998.161:1078-1082.
18. Li-Weber, M., Laur, O., Hekele, A., Coy, J., Walczak, H. and Krammer, P. H., A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 1998. 28: 2373-2383.
19. Matsui, K., Fine, A., Zhu, B., Marshak-Rothstein, A. and Ju, S.-T., Identification of two NF-xB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 1998.161: 3469-3473.
20. Kasibhatla, S., Genestier, L. and Green, D. R., Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via NF-xB. J. Biol. Chem. 1999.274:987-992.
21. Teixeiro, E., Garcia-Sahuquillo, A., Alarcon, B. and Bragado, R., Apoptosis-resistant T cells have a deficiency in NF-y.B-mediated induction of Fas ligand transcription. Eur. J. Immunol. 1999. 29: 745-754.
22. Lee, M.-R., Liou, M.-L., Liou, M.-L., Yang, Y.-F. and Lai, M.-Z., cAMP analogs prevent activation-induced apoptosis of T cell hybridoma. J. Immunol. 1993. 151: 5208-5217.
23. Chen, D. and Rothenberg, E. V., Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinational transcription roles. J. Exp. Med. 1994.179: 931-942.
24. Neumann, M., Grieshammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M., Schimpl, A., Franza, Jr., B. R. and Serfling, E., RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 1995. 14:1991-2004.
25. Ho, H.-Y., Lee, H.-H. and Lai, M.-Z., Overexpression of mitogen-activated protein kinase kinase kinase reverses cAMP inhibition of NF-x.B in T cells. Eur. J. Immunol. 1997.27:222-226.
26. Hsueh, Y.-P. and Lai, M.-Z., JNK but not MAP kinase is sensitive to cAMP in T lymphocytes. J. Biol. Chem. 1995.270:18094-18098.
27. Schulze-Osthoff, K., Krammer, P. H. and Droge, W., Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO. J. 1994. 13: 4587-4596.
28. Hsu, S.-C., Wu, C.-C., Luh, T.-Y., Chou, C.-K., Hän, S.H. and Lai, M.-Z., Apoptotic signal of Fas is not mediated by ceramide. Blood 1998. 91: 2658-2663.
29. Muller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M. and Krammer, P. H., p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 1998. 188: 2033-2045.
30. Jain, J., Loh, C. and Rao, A., Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995.7:733-742.
31. Garrity, P. A., Chen, D., Rothenberg, E. V. and Wold, B. J., lnterleukin-2 transcription is regulated in vitro at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 1994. 14: 2159-2169.
32. Chan, H., Bartos, D. P. and Owen-Schaub, L. B., Activation-dependent transcriptional regulation of the human fas promoter requires NF-v.B p50-p65 recruitment. Mol. Cell. Biol. 1999.19: 2098-2108.
33. Beg, A. A. and Baltimore, D., An essential role for NFv.B in preventing TNF-a-induced cell death. Science 1996.274:782-784.
34. Wang, C. Y., Mayo, M. W. and Baldwin, A. S., TNF- and Cancer therapy-induced apoptosis: potentiation by inhibition of NF-xB. Science 1996. 274: 784-787.
35. Van Antewerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M., Suppression of TNF-ct-induced apoptosis by NF-y.B. Science 1996. 274: 787-789.
36. Schreck, R., Rieber, R. and Baeuerle, P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-xB transcription factor and HIV-1. EMBOJ. 1991.10:2247-2258.
37. Sulciner, D. J., Irani, K., Yu, Z. X., Ferrans, V. J., Goldschmidt-Clemont, P. J. and Finkel, T., Rad regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-y.B activation. Mol. Cell. Biol. 1996.16: 7115-7121.
38. Li, Y., Zhang, W., Mantel), L. L., Kazzar, J. A., Fein, A. M. and Horowitz, S., Nuclear factor-J.B is activated by hyperoxia but does not protect from cell death. J. Biol. Chem. 1997. 272: 20646-20649.
39. Li, N. and Karin, M., Ionizing radiation and short wavelength UV activate NF-xB through two distinct mechaMijsms. Proc. Natl. Acad. Sei. USA 1998. 95: ''13012-13017.
40. Williams, M. S. and Henkart, P. A., Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 1996.157: 2395-2402.
41. Yonehara, S., Ishii, A. and Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with receptor of tumor necrosis factor. J. Exp. Med. 1989.169:1747-1756.
42. Ballard, D. W., Dixon, E. P., Perfer, N. J., Bogerd, H., Doeree, S., Stein, B. and Greene, W. C., The 65-kDa subunit of human NF-xB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sei. USA 1992. 89:1875-1879.
43. Jain, J., McCaffrey, P. G., Miner, Z., Kerppola, T. K., Lambert, J. N., Verdine, G. L., Curran, T. and Rao, A., The T-cell transcriptional factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993. 365: 352-355.
44. Collette, Y., Razanajaona, D., Ghiotto, M. and Olive, D., CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism. Eur. J. Immunol. 1997. 27: 3283-3289.
45. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. and Riccardi, C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991. 139:271-279.
46. Hsueh, Y.-P., Liang, H.-E., Ng, S.-Y. and Lai, M.-Z., CD28 costimulation activates CREB in T lymphocytes. J. Immunol. 1997.158: 85-93.